Outgoing Valeant CEO Tells Senators That Drug Price Boost Was 'A Mistake'

Appearing before the Senate Special Committee on Aging, J. Michael Pearson tells lawmakers that he regrets significantly raising the price of certain drugs. Also testifying are Valeant investor and board member William Ackman and former CFO Howard Schiller.